The comprehensive 2,400 page research study on COVID-19 therapeutic and vaccine pipeline candidates, completed, ongoing and planned clinical trials across phases, countries, companies and institutes/hospitals.
The global COVID-19 market size outlook remains robust driven by huge potential for administration to 2 billion populations, vast diagnostics market revenue outlook, marketing agreements with governments, approval and launch of diverse drugs and ongoing investments in R&D pipeline of COVID-19 will strengthen the market demand.
COVID Pipeline Snapshot, January 2021 COVID-19 pipeline comprises of 639 drug candidates under development as of December 2020. The pipeline is characterized by presence of both large scale companies and small players. Large companies including Novartis, Pfizer, Zydus, Roche, Sanofi and GlaxoSmithKline continue to invest in treatment options vaccination candidates.
Among pre-clinical and research phase candidates, several companies are looking for partnering with other companies or universities to advance their research studies. ‘Immunostimulants’ is among the most researched ‘mechanism of action’ in the pipeline.
Among drug and vaccine candidates in clinical trials (Phase 1 to Phase 3), 155 of 263 candidates are new molecular entities. Of the 639 drug candidates in development, 75 drug/vaccine candidates are identified in Phase 3 while 131 candidates are in Phase 2. 55 candidates are in Phase 1 and 235 candidates are in preclinical study phase. Further, the number of drug and vaccine candidates in research study phase stood at 134.
COVID Clinical Trials Snapshot, 2021 During the observation period, 1726 COVID-19 trials have been initated and an additional 534 clinical trials are planned to commence. Of the total 2260 trials studied in the research, 957 trials are in Phase 2, 748 trials are in Phase 3, 321 trials in Phase 0 and Phase 1, and 228 trials in Phase 4. In terms of enrollment, 70% of subjects are recruited/or planned for Phase 3. Around 78% of trials are recruiting or planning to recruit subjects for their pipeline product development. Over 26% of trials are directly sponsored by pharmaceutical companies with the remaining 74% being sponsored indirectly by companies or sponsored by institutions. Among countries, the US stood the largest market worldwide, accounting for 539 clinical trials. Among economy types, advanced and emerging economies share an almost equal volume of trials with the former accounting for 52% of trial count.
Scope of the report- • COVID-19 pipeline report identifies 650+ companies active in 2021 • Pre-clinical drug candidates, research phase COVID-19 compounds, New Molecular entities, Phase 0, Phase 1, Phase 2, Phase 3, Pre-registration, IND and other phase COVID-19 pipeline products are included • Business profiles and snapshots of all major companies are presented in the report • Recent market developments in the COVID-19 vaccines and treatment products • 1500+ Clinical trials details including snapshot, companies, institutes, phase, start date, completion date, recruitment, enrolment and other details • Drug candidate, Vaccine candidate details including current status, companies involved, new molecular entity, phase, mechanism of action, recent developments, route of administration and other details analyzed for each candidate
Our reports have been used by over 10K customers, including:
The North America organoids market is expected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019. The market is anticipated to grow at a CAGR of 21.7% from 2020 to 2027. Growth of the North America organoids market is attributed to emergence of three-dimensional (3D) organoids and rise in investments in research. However,...
The global in vivo toxicology market size is projected to reach USD 6.6 billion by 2025 from USD 5.0 billion in 2020, at a CAGR of 5.5% during the forecast period. Market growth is driven largely by the increasing pharmaceutical R&D activities, innovations in animal models, the development of exclusive in vivo toxicology tests, and the increasing...
185 pages •
By Global Industry Analysts
• Apr 2021
- Global Pathology Instruments Market to Reach $4.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Pathology Instruments estimated at US$3 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027....
KEY FINDINGS The global irritable bowel syndrome treatment market is predicted to grow with a CAGR of 7.25%, during the forecast period of 2021 to 2028. The market growth is mainly fueled by factors like, the rising prevalence of gastrointestinal ailments, the increasing number of FDA approvals and drug developments, the...
Nordic Regulatory Affairs Market Size, Share & Trends Analysis Report By Service, By Service Provider, By Company Size, By Category, By Product Stage, By Indication, By End-use, By Country, And Segment Forecasts, 2021 - 2028 Nordic Regulatory Affairs Market Growth & Trends The Nordic regulatory...
Botulism (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Botulism - Drugs in Development, 2021, provides an overview of the Botulism (Infectious Disease) pipeline landscape. Botulism is a rare but serious illness. The...
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
175 pages •
By The Business Research Company
• Apr 2021
Major players in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market are Abbott Laboratories, Agilent Technologies Inc., Biomerieux Sa, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd (Roche Diagnostics), Qiagen N.V., Genmark Diagnostics, Thermo Fisher Scientific Inc., General Electric Company (Ge...
Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Service (Clinical Monitoring, Regulatory/Medical Affairs), And Segment Forecasts, 2021 - 2028 Healthcare CRO Market Growth & Trends The global healthcare...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.